Frapolli, R <br/><br/>
Pharmacokinetics and metabolism in mice of IDN 5390 (13-(N-Boc-3-i-butylisoserinoyl)-C-7,8-seco-10-deacetylbaccatin III), a new oral c-seco-taxane derivative with antiangiogenic property effective on paclitaxel-resistant tumors.  [electronic resource] 

 -  Drug metabolism and disposition: the biological fate of chemicals  Dec 2006 
 - 2028-35 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0090-9556 
<br/><br/><label>Standard No.: </label>10.1124/dmd.106.012153  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--pharmacokinetics<br/>Animals<br/>Antineoplastic Agents, Phytogenic<br/>Biological Availability<br/>Bridged-Ring Compounds--pharmacokinetics<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Drug Resistance, Neoplasm<br/>Feces--chemistry<br/>Female<br/>Mice<br/>Mice, Inbred Strains<br/>Microsomes, Liver--metabolism<br/>Paclitaxel<br/>Taxoids--pharmacokinetics<br/>Tissue Distribution